Siddharth Kaul
Vermögen: - $ am 31.05.2026
Vermögen: - $ am 31.05.2026
Siddharth Kaul is currently an Independent Non-Executive Director at Immunocore Holdings Plc since 2022 and a Non-Executive Director at Immunocore Ltd. Former positions include Director at Helsinn Healthcare SA and Group Treasurer & Head-Business Planning at Novartis AG.
Education includes an MBA from Indiana University and an undergraduate degree from West Virginia University.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 27.05.2026 | 0 ( -.--% ) | - $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| IMMUNOCORE HOLDINGS PLC | Direktor/Vorstandsmitglied | 08.06.2022 |
Immunocore Ltd.
Immunocore Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes transformative medicines for cancer, infection and autoimmune disease | Direktor/Vorstandsmitglied | - |
| Unternehmen | Position | Ende |
|---|---|---|
| NOVARTIS AG | Corporate Officer/Principal | - |
Helsinn Healthcare SA
Helsinn Healthcare SA Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Direktor/Vorstandsmitglied | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 6 |
|---|---|
Helsinn Healthcare SA
Helsinn Healthcare SA Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Novartis AG
Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Indiana University
Indiana University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
West Virginia University
West Virginia University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Immunocore Holdings Plc
Immunocore Holdings Plc BiotechnologyHealth Technology Operates as a biotechnology company which develops immunotherapies | Health Technology |
Immunocore Ltd.
Immunocore Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes transformative medicines for cancer, infection and autoimmune disease | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen